Key Points
- Sanjeev Mehra purchased 125,000 Avantor shares on March 10 at an average price of $8.01 for a total of ~$1.001M, boosting his stake 35.71% to 475,000 shares valued at about $3.8M.
- Avantor beat Q4 estimates with $0.22 EPS (vs. $0.21 expected) on $1.66B revenue (down 1.4% YoY) and set FY2026 guidance of 0.770–0.830 EPS, while analysts forecast ~1.06 EPS for the current fiscal year.
- The stock traded at $8.40 (up 1.3%) with a $5.73B market cap, a consensus rating of Hold and an average price target of $11.80 (analyst range roughly $8–$14); institutional investors own ~95% of shares.
Avantor, Inc. (NYSE:AVTR - Get Free Report) Director Sanjeev Mehra purchased 125,000 shares of the company's stock in a transaction that occurred on Tuesday, March 10th. The stock was purchased at an average price of $8.01 per share, for a total transaction of $1,001,250.00. Following the purchase, the director owned 475,000 shares in the company, valued at $3,804,750. This represents a 35.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Avantor Stock Up 1.3%
NYSE:AVTR traded up $0.11 on Thursday, reaching $8.40. 462,985 shares of the stock traded hands, compared to its average volume of 12,264,904. The company has a market capitalization of $5.73 billion, a price-to-earnings ratio of -10.72, a PEG ratio of 3.20 and a beta of 0.97. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. Avantor, Inc. has a 12 month low of $7.82 and a 12 month high of $17.11. The company's fifty day simple moving average is $10.51 and its 200 day simple moving average is $11.75.
Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The business had revenue of $1.66 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same period in the previous year, the company earned $0.27 earnings per share. The business's revenue for the quarter was down 1.4% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Equities analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.
Institutional Trading of Avantor
Large investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC increased its position in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock valued at $29,000 after acquiring an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in Avantor in the second quarter worth about $32,000. Private Trust Co. NA grew its stake in shares of Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company's stock valued at $32,000 after purchasing an additional 875 shares during the period. Osaic Holdings Inc. increased its position in shares of Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. Finally, Los Angeles Capital Management LLC purchased a new stake in shares of Avantor during the 4th quarter valued at about $32,000. Institutional investors own 95.08% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on AVTR shares. Jefferies Financial Group reaffirmed an "underperform" rating and issued a $8.00 price objective on shares of Avantor in a research report on Thursday, February 12th. Robert W. Baird set a $11.00 target price on Avantor in a report on Thursday, February 12th. Morgan Stanley set a $10.00 price target on Avantor in a research note on Friday, February 13th. Citigroup lowered their price target on Avantor from $13.00 to $11.00 and set a "neutral" rating on the stock in a report on Thursday, February 12th. Finally, Wells Fargo & Company reduced their price objective on Avantor from $16.00 to $14.00 and set an "overweight" rating for the company in a report on Friday, February 13th. Three investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, Avantor currently has a consensus rating of "Hold" and an average price target of $11.80.
Check Out Our Latest Report on AVTR
About Avantor
(
Get Free Report)
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
